Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.95 USD | -1.12% | -15.52% | +98.75% |
Mar. 15 | XBiotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 04 | XBiotech Inc. to Begin Constructing New R&D Facility on Its 48-Acre Campus | CI |
Financials (USD)
Sales 2022 | 4.01 | Sales 2023 | - | Capitalization | 122M |
---|---|---|---|---|---|
Net income 2022 | -32M | Net income 2023 | -24M | EV / Sales 2022 | -27,590,059 x |
Net cash position 2022 | 217M | Net cash position 2023 | 200M | EV / Sales 2023 | - |
P/E ratio 2022 |
-3.25
x | P/E ratio 2023 |
-4.94
x | Employees | 82 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 63.98% |
1 day | -1.12% | ||
1 week | -15.52% | ||
Current month | -2.21% | ||
1 month | +6.00% | ||
3 months | +76.67% | ||
6 months | +110.60% | ||
Current year | +98.75% |
Managers | Title | Age | Since |
---|---|---|---|
John Simard
CEO | Chief Executive Officer | 62 | 05-03-21 |
Angela Hu
DFI | Director of Finance/CFO | 40 | 14-12-31 |
Mark Ziats
CTO | Chief Tech/Sci/R&D Officer | - | 21-08-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald MacAdam
BRD | Director/Board Member | 76 | 18-03-19 |
William McKenzie
BRD | Director/Board Member | 76 | 09-01-31 |
John Simard
CEO | Chief Executive Officer | 62 | 05-03-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 7.95 | -1.12% | 58,090 |
24-04-19 | 8.04 | +1.64% | 76,250 |
24-04-18 | 7.91 | -2.47% | 98,767 |
24-04-17 | 8.11 | -9.49% | 81,922 |
24-04-16 | 8.96 | -4.78% | 110,190 |
Delayed Quote Nasdaq, April 22, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+98.75% | 242M | |
+2.49% | 96.73B | |
-0.23% | 21.31B | |
-16.61% | 21.21B | |
-5.10% | 18.79B | |
-42.14% | 16.37B | |
-27.40% | 13.68B | |
+1.44% | 13.44B | |
+21.29% | 10.98B | |
-21.79% | 8.56B |
- Stock Market
- Equities
- XBIT Stock